Trust Co. of Toledo NA OH grew its position in shares of CVS Health Co. (NYSE:CVS) by 1.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 27,655 shares of the pharmacy operator’s stock after acquiring an additional 325 shares during the quarter. Trust Co. of Toledo NA OH’s holdings in CVS Health were worth $2,081,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. First Trust Advisors LP increased its holdings in shares of CVS Health by 1.2% during the fourth quarter. First Trust Advisors LP now owns 1,320,232 shares of the pharmacy operator’s stock valued at $90,172,000 after acquiring an additional 15,828 shares in the last quarter. Kingfisher Capital LLC increased its holdings in shares of CVS Health by 7.7% during the fourth quarter. Kingfisher Capital LLC now owns 21,834 shares of the pharmacy operator’s stock valued at $1,491,000 after acquiring an additional 1,569 shares in the last quarter. Pzena Investment Management LLC increased its holdings in shares of CVS Health by 6.5% during the fourth quarter. Pzena Investment Management LLC now owns 1,233,975 shares of the pharmacy operator’s stock valued at $84,280,000 after acquiring an additional 75,581 shares in the last quarter. Madison Wealth Management grew its holdings in CVS Health by 41.3% during the fourth quarter. Madison Wealth Management now owns 85,514 shares of the pharmacy operator’s stock worth $5,841,000 after buying an additional 24,995 shares in the last quarter. Finally, Norges Bank bought a new stake in CVS Health during the fourth quarter worth $964,912,000. Hedge funds and other institutional investors own 74.21% of the company’s stock.
CVS stock traded down $0.80 during midday trading on Thursday, hitting $73.69. The company’s stock had a trading volume of 97,772 shares, compared to its average volume of 7,071,797. The stock’s 50-day moving average price is $72.43 and its 200 day moving average price is $68.51. The company has a quick ratio of 0.67, a current ratio of 0.95 and a debt-to-equity ratio of 0.89. CVS Health Co. has a 1 year low of $55.36 and a 1 year high of $77.23. The stock has a market cap of $96.63 billion, a price-to-earnings ratio of 12.24, a PEG ratio of 1.72 and a beta of 0.82.
The company also recently declared a quarterly dividend, which will be paid on Monday, May 3rd. Stockholders of record on Friday, April 23rd will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Thursday, April 22nd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.71%. CVS Health’s dividend payout ratio is presently 28.25%.
In related news, SVP James David Clark sold 5,350 shares of the business’s stock in a transaction on Wednesday, March 31st. The stock was sold at an average price of $76.00, for a total transaction of $406,600.00. Also, EVP Alan Lotvin sold 25,836 shares of the business’s stock in a transaction on Friday, January 8th. The shares were sold at an average price of $75.00, for a total value of $1,937,700.00. Following the sale, the executive vice president now owns 18,469 shares in the company, valued at $1,385,175. The disclosure for this sale can be found here. Insiders have sold a total of 594,375 shares of company stock worth $44,673,602 in the last ninety days. Insiders own 0.46% of the company’s stock.
Several equities research analysts recently issued reports on CVS shares. Jefferies Financial Group upgraded CVS Health from a “hold” rating to a “buy” rating and set a $90.00 price target for the company in a report on Friday, January 8th. SVB Leerink upped their price target on CVS Health from $73.00 to $80.00 and gave the stock a “market perform” rating in a report on Monday, December 14th. Finally, Guggenheim reiterated a “neutral” rating on shares of CVS Health in a report on Tuesday, March 23rd. Four analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $82.08.
CVS Health Company Profile
CVS Health Corporation provides health services in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services.
Further Reading: How liquidity affects the bid-ask spread
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.